• In Canada, Apharia, Canopy Growth Corp, Tilray and Ayurcann are seizing opportunities created by new legislation.

  • The CBD market size in Canada alone is heading for $2Billion.

Over the past four years since Canada officially legalized cannabis, we’ve watched as the industry’s green wave swept the Nation. While most of the country is hyper focused on THC and its psychoactive effects, CBD continues to trend as one of the most popular cannabinoids due to its unique health and medical benefits – albeit without all the buzz of THC.

From consumption to sales, manufacturing and investment, the Canadian CBD market continues to trend upward. In fact, just two years after legalization, the Canadian Health Food Association (CHFA) reported that the Canadian CBD market has grown to the size of $2 billion CAD. Furthermore, the group projects that this number will continue to increase by 7% yearly.

As part of the process of familiarizing oneself with Canada’s increasing commercialization of CBD, we’ll take a deep dive into a perfect example of this growth in the form of Ayurcann - one of the biggest players in the CBD commercialization scene.

Ayurcann’s Background:

Since legalization, Ayurcann has demonstrated unparalleled execution and capital deployment efficiency as shown by the timeline of success from the company’s initial Health Canada Application in 2018 to the report of $7,500,000 in revenue by 2021.

Today, Ayurcann is the leading post-harvest solution provider with a focus on providing and creating custom processes and pharma-grade products for the adult-use and the medical cannabis industry in Canada. Through extraction and refinement, bulk oil sales, and white labeling manufacturing, Ayrucann is now setting the standard for what’s considered Canadian ‘top-shelf’ CBD goods.

Ayurcann on the Shelves

WIth the industry’s exponential growth, Ayurcann is now one of the top producers of medical tinctures, vape pens, topicals, and white-labeled products for the most highly-sought after brands.

Among the many brands they work with one can find:

● Her Highness NYC

● Innocan Pharma

● Fuego

● Hustle & Shake

Altogether, Ayurcann’s current market share now amounts to a total of 87 Canadian national listings, 21 product SKUs, and nine recreational cannabis brands.

Looking Ahead: The Future of Canadian CBD

In today’s ‘new normal’, stress and anxiety are at an all-time high, which explains consumers’ drive towards all-natural healing solutions. This, along with the rise in availability of legal CBD goods is causing CBD to become a mass trend that is in high demand.

While one glaring issue had been known across the industry in the past, it is now being addressed by local officials causing a monumental shift in the market. That being, the illegal sales of unregulated CBD products on Canada’s illicit market. As authorities continue to crackdown for consumer safety purposes, a rush of consumers are seeking the shelves for high-quality, refined, tested, and transparent CBD products.

Final take:

In Canada, Apharia, Canopy Growth Corp, Tilray and Ayurcann are seizing opportunities created by new legislation. The fundamentals of these companies are all supported by new relaxed laws. Since its inception in 2018, Ayurcann’s team has positioned its brand to capitalize on the natural evolution of the cannabis and CBD market. A goal the brand only plans to continue in 2022, and beyond. It seems that Ayurcann demonstrates the vast potential in the CBD market. They could be well poised for bigger moves soon as the CBD industry continues to flourish and the Canadian CBD market continues its growth.